secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2026-09-15T12:54:35+00:00
Accession:  0001437749-26-030392
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences completes 100-patient enrollment in PRECISE-BTN thyroid nodule study
--------------------------------------------------------------------------------

- PRECISE-BTN study of nPulse Vybrance system fully enrolled 100 patients (expanded from original 50) by August 2026.
- First enrolled patient completed final 12-month follow-up in August at Sarasota Memorial Health Care System.
- Patients enrolled across three U.S. sites: Sarasota Memorial, NYU Langone Health, Weill Cornell Medicine in about 12 months.
- Preliminary data expected at upcoming medical conference; full data after all patients complete 12-month follow-up.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926030392/0001437749-26-030392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926030392/plse20260827_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-030392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer